NSAA-based Therapy Demonstrates Remarkable Results in Brazil COVID-19 Study Substantially Lowering Mortality Rate

NSAA-based Therapy Demonstrates Remarkable Results in Brazil COVID-19 Study Substantially Lowering Mortality Rate

A nonsteroidal antiandrogen (NSAA), classified as a selective, high-affinity silent antagonist of the androgen receptor (AR), currently under development by a Chinese biotech company was selected by a team of Brazilian clinical investigators to determine if the drug could treat COVID-19, reducing mortality risk while condensing median hospitalization duration. An investigator-initiated trial (meaning sponsored by the physician/researchers), namely Dr. Andy Goren and Dr. Flavio Adsuara Cadegiani involving 12 trial sites across Brazil under the Applied Biology Inc. umbrella, the results may have pleasantly surprised all as the randomized, placebo-controlled, double-blinded, parallel assignment study revealed that Proxalutamide lessened the mortality risk associated with COVID-19 by 92% while the actual duration of hospitalization condensed by a median of nine (9) days. As might not be surprising, these tremendous results received little media attention in any mainstream press. Note that this study was conducted in a region of the world with a high death rate associated with severe COVID-19 and hospitalization.  The study sites involved hospitals in North Brazil (Amazonas) and by mid...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee